TP53 and non-small cell lung carcinoma: Recent studies involving treatment non-small cell lung cancer (NSCLC) patients and a mouse model using KrasG12D and P53 null (KP) epithelial cells have highlighted the significant role of tissue-resident AMs in driving lung tumorigenesis [47].